309 related articles for article (PubMed ID: 16207172)
1. Molecular mechanisms of HIV-1 proviral latency.
Bisgrove D; Lewinski M; Bushman F; Verdin E
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):805-14. PubMed ID: 16207172
[TBL] [Abstract][Full Text] [Related]
2. Latency: the hidden HIV-1 challenge.
Marcello A
Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
[TBL] [Abstract][Full Text] [Related]
3. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
4. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
[TBL] [Abstract][Full Text] [Related]
5. Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.
Pomerantz RJ
Arch Immunol Ther Exp (Warsz); 2004; 52(5):297-306. PubMed ID: 15507870
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human immunodeficiency virus-1 latency and its reactivation.
Verdin E
Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque S; Gaudray G; Veithen E; Bours V; Piette J; Burny A
Bull Mem Acad R Med Belg; 2004; 159(Pt 2):176-89. PubMed ID: 15615091
[TBL] [Abstract][Full Text] [Related]
8. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
[TBL] [Abstract][Full Text] [Related]
9. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
[TBL] [Abstract][Full Text] [Related]
10. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
[TBL] [Abstract][Full Text] [Related]
11. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
Hezareh M
Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
[TBL] [Abstract][Full Text] [Related]
12. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.
Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ
AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582
[TBL] [Abstract][Full Text] [Related]
13. HIV reservoirs, latency, and reactivation: prospects for eradication.
Dahl V; Josefsson L; Palmer S
Antiviral Res; 2010 Jan; 85(1):286-94. PubMed ID: 19808057
[TBL] [Abstract][Full Text] [Related]
14. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
15. Experimental approaches to the study of HIV-1 latency.
Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Latency and Eradication: Past, Present and Future.
Datta PK; Kaminski R; Hu W; Pirrone V; Sullivan NT; Nonnemacher MR; Dampier W; Wigdahl B; Khalili K
Curr HIV Res; 2016; 14(5):431-441. PubMed ID: 27009094
[TBL] [Abstract][Full Text] [Related]
17. Eradication of HIV in infected patients: some potential approaches.
Yang QE
Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518
[TBL] [Abstract][Full Text] [Related]
18. Latency and viral persistence in HIV-1 infection.
Siliciano JD; Siliciano RF
J Clin Invest; 2000 Oct; 106(7):823-5. PubMed ID: 11018068
[No Abstract] [Full Text] [Related]
19. [HIV eradication--facts and fiction].
Jaeger H; Wolf E
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
[No Abstract] [Full Text] [Related]
20. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification.
Imai K; Ochiai K; Okamoto T
J Immunol; 2009 Mar; 182(6):3688-95. PubMed ID: 19265147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
